shortagewatch

Home / Companies / Bgp

Company family

Bgp: medicine shortages

As of 2 Nov 2026, 29 Bgp products have a reported shortage across 1 countries, covering 18 medicines.

Products short29rank #73 of 464
Medicines18active ingredients
Countries1/16
New in 90 days9+1 vs market pace
Typical duration3 monthsmedian so far
Manufacturing69%demand-driven 17%

Where

Canada29

Which therapeutic classes

Nervous system11Cardiovascular system9Genito-urinary system and sex hormones5Anti-infectives1Systemic hormones1Digestive tract and metabolism1Sensory organs1

Why, compared with all companies

Manufacturing problemIncreased demandActive ingredient shortageDistribution or logisticsCommercial decision or withdrawalRegulatory or licensingOtherNot stated
BgpBgp: Manufacturing problem 20 (69%)69%Bgp: Increased demand 5 (17%)17%Bgp: Active ingredient shortage 2 (7%)7%Bgp: Distribution or logistics 1 (3%)Bgp: Other 1 (3%)All companiesAll companies: Manufacturing problem 4,893 (36%)36%All companies: Increased demand 1,873 (14%)14%All companies: Active ingredient shortage 367 (3%)All companies: Distribution or logistics 336 (2%)All companies: Commercial decision or withdrawal 435 (3%)All companies: Regulatory or licensing 131 (1%)All companies: Other 1,244 (9%)9%All companies: Not stated 4,221 (31%)31%

Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.

Latest changes

All changes

No changes recorded yet. Changes are tracked from our daily snapshots.

When its current shortages began

01235Dec: 0Jan ’25: 0Feb: 0FebMar: 0Apr: 0May: 0MayJun: 0Jul: 0Aug: 0AugSep: 0Oct: 0Nov: 0NovDec: 1Jan ’26: 1Feb: 1FebMar: 0Apr: 0May: 1MayJun: 2Jul: 1Aug: 1AugSep: 3Oct: 5Nov: 0Nov

Long-run trend in Canada

Canada dashboard
02550751002017: 2020172018: 2120182019: 4320192020: 5820202021: 3320212022: 2720222023: 3520232024: 2920242025: 4020252026: 552026

Canada publishes every report since 2017, so it shows whether this company is reporting more or fewer shortages over time. The current year is partial.

Against its peers

Viatris995Teva903Sandoz599Pfizer491Accord (Intas)484Stada349Zentiva340Fresenius Kabi339Apotex326Sun Pharma250Aurobindo226Towa (Pensa)201Krka187Sanofi158Bgp29

Breadth vs depth

1101001,00010,0001101001,000Products short (log scale)Medicines affected (log scale)Viatris: 995 / 248ViatrisTeva: 903 / 289TevaSandoz: 599 / 198SandozPfizer: 491 / 122PfizerAccord (Intas): 484 / 151Accord (Intas)Stada: 349 / 140Zentiva: 340 / 159ZentivaFresenius Kabi: 339 / 81Apotex: 326 / 152Sun Pharma: 250 / 77Aurobindo: 226 / 111Towa (Pensa): 201 / 102Krka: 187 / 67Sanofi: 158 / 45Jamp: 151 / 74Baxter: 149 / 27Sawai: 148 / 68Hikma: 126 / 44Glenmark: 105 / 39Sanis: 98 / 54Cheplapharm: 86 / 28GSK: 85 / 38Advanz (Amdipharm): 81 / 24Nichi-Iko: 77 / 29Takeda: 76 / 10Johnson & Johnson: 75 / 19Neuraxpharm: 75 / 19Novartis: 70 / 32Bayer: 68 / 17Biomed: 64 / 21Daiichi Sankyo: 59 / 18Orifarm: 59 / 40Medochemie: 56 / 14Pharmascience: 51 / 32Marcan: 51 / 16Doc Generici: 50 / 25B. Braun: 49 / 17AA Pharma: 46 / 26H E: 46 / 15Octapharma: 42 / 6Jv E: 42 / 1Kyowa Pharmaceutical: 42 / 16Novo Nordisk: 41 / 8Odan: 41 / 31Aspen: 41 / 13Sterop: 41 / 16Nipro: 41 / 17Dr. Reddy's: 40 / 24Organon: 40 / 20Laboratoire Riva: 40 / 23Kern Pharma: 40 / 30Bausch Health: 39 / 30Bracco: 38 / 6G.L.: 38 / 13Tatsumi Kagaku: 38 / 24Otsuka: 37 / 4Eli Lilly: 37 / 12Piramal Critical: 35 / 13Imuna Pharm: 35 / 4AbbVie: 34 / 15Medical Valley: 34 / 8Orion: 34 / 24Rowex: 34 / 19Takata Pharmaceutical: 33 / 17Aristo: 32 / 16Norgine: 32 / 3Gedeon Richter: 31 / 11Eql: 31 / 9Guerbet: 30 / 5Lukas Heil-Betriebsst: 30 / 0Roche: 29 / 14Omega: 29 / 18Holsten -: 29 / 3Menarini: 29 / 17Paladin: 28 / 17Grifols: 28 / 9Ge: 28 / 6Merck & Co. (MSD): 27 / 14Ferring: 27 / 7Bgp: 29 / 18Bgp

Further right: more products short. Higher: more different medicines affected.

Medicines short

Download CSV
MedicineWhere this company is shortProductsEarliest startMain reasonShort anywhere
Gabapentin35 Jan 2026Active ingredient shortage9/16
Sertraline325 Sep 2026Manufacturing problem11/16
Ziprasidone33 Jun 2026Manufacturing problem7/16
Atorvastatin and Amlodipine28 Nov 2026Manufacturing problem2/16
Sildenafil28 Nov 2026Manufacturing problem10/16
Testosterone216 Oct 2026Manufacturing problem3/16
Trandolapril21 Jun 2026Manufacturing problem4/16
Verapamil224 Jan 2020Distribution or logistics5/16
Atorvastatin130 Jul 2026Manufacturing problem11/16
Clarithromycin18 Dec 2016Manufacturing problem5/16
Eletriptan121 May 2026Manufacturing problem7/16
Eplerenone120 Nov 2026Manufacturing problem6/16
Glyceryl Trinitrate11 Sep 2026Manufacturing problem6/16
Levothyroxine Sodium126 Oct 2026Increased demand6/16
Multienzymes (Lipase, Protease etc.)17 Oct 2026Other7/16
Pregabalin16 Dec 2026Manufacturing problem11/16
Timolol, Combinations13 Dec 2026Increased demand9/16
Tolterodine130 Dec 2025Increased demand8/16

Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.